DRG

Delaware Resource Group of Oklahoma, LLC (DRG) and Alutiiq Career Ventures, LLC (ACV) announce a strategic partnership

Retrieved on: 
Friday, April 5, 2024
Organization, SBA, Partnership, Aerospace, DRG, National Guard Bureau, NASA, Safety, ACV

ANCHORAGE, Alaska, April 05, 2024 (GLOBE NEWSWIRE) -- Delaware Resource Group of Oklahoma, LLC (DRG) and Alutiiq Career Ventures, LLC (ACV) announce they have entered into a Mentor-Protégé Agreement, which is pending approval by the U.S. Small Business Administration (SBA).

Key Points: 
  • ANCHORAGE, Alaska, April 05, 2024 (GLOBE NEWSWIRE) -- Delaware Resource Group of Oklahoma, LLC (DRG) and Alutiiq Career Ventures, LLC (ACV) announce they have entered into a Mentor-Protégé Agreement, which is pending approval by the U.S. Small Business Administration (SBA).
  • “We are grateful for this opportunity to work with such an accomplished company as DRG and look forward to entering the Aerospace and Training marketplace,” said Matt Nelson, President of ACV.
  • ACV, as the Protégé, will gain valuable experience in preparing solicitation responses to diversify its portfolio and pursue new opportunities in the future.
  • “We are excited to see two great organizations come together to achieve mutually beneficial opportunities.

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Wednesday, March 13, 2024
Health, Neurology, Genetics, Clinical Trials, Pharmaceutical, Biotechnology, STAC, Gene, Orphan drug, ALTA, Haemophilia A, BBB, Patient, Health care, Quality of life, IND, Male, ERT, Investment, Therapy, Fabry disease, Plasma, Kite, Gene expression, Partnership, Central nervous system, Novartis, CNS, Pivotal, EMA, Prion, STAAR, Enzyme replacement therapy, Biogen, Tauopathy, Workforce, BLA, AAV, Sanofi, Research, DRG, Neuron, Hematology, FDA, DSM-IV codes, Brain, Sangamo Therapeutics, MAA, Haemophilia, CTA, Mouse, Female, Traffic barrier, Sodium, MHRA, Excipient, Society, Spinal cord, Toxicology, Sigma-Aldrich, Liver, Pharmaceutical industry

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and fourth quarter and full year 2023 financial results, including meaningful data to support advancement of its neurology pipeline.

Key Points: 
  • Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and fourth quarter and full year 2023 financial results, including meaningful data to support advancement of its neurology pipeline.
  • “In 2023, Sangamo announced the prioritization of its pipeline programs that support our focus as a neurology-focused genomic medicine company,” said Sandy Macrae, Chief Executive Officer of Sangamo.
  • STAC-BBB was well tolerated in NHPs, with no notable treatment related pathological findings in brain, spinal cord or peripheral tissues.
  • Revenues for the fourth quarter ended December 31, 2023 were $2.0 million, compared to $27.2 million for the same period in 2022.

Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs

Retrieved on: 
Wednesday, March 13, 2024
Research, Neurology, Genetics, Clinical Trials, Health, Pharmaceutical, General Health, Other Science, Science, STAC, AAV, Sangamo Therapeutics, Gene, Brain, Capsid, Gene expression, ALS, BBB, Central nervous system, Novartis, CNS, CTA, DRG, Traffic barrier, Prion, NHP, Tropism, IND, Nav1.7, Neuron, Biogen, Tauopathy, Excipient, Therapy, DSM-IV codes, Spinal cord, Liver, Animal, Vaccine

Sangamo is exploring avenues to resume development of these programs internally, subject to receipt of adequate funding, or with new potential collaborators.

Key Points: 
  • Sangamo is exploring avenues to resume development of these programs internally, subject to receipt of adequate funding, or with new potential collaborators.
  • In NHP studies when administered intravenously at clinically relevant doses, STAC-BBB demonstrated its potential to be a leading neurotropic capsid.
  • Exhibited 700-fold higher transgene expression in neurons compared to the benchmark capsid AAV9 and outperformed all other known published neurotropic capsid variants evaluated in the study.
  • STAC-BBB was well tolerated in NHPs, with no notable treatment related pathological findings in brain, spinal cord or peripheral tissues.

Zelis® Payment Integrity Named 2024 Best in KLAS, Outpacing the Industry for Client Experience, with System Integration and Achieved Client Outcomes

Retrieved on: 
Wednesday, February 7, 2024
Data Management, Practice Management, Technology, Professional Services, Managed Care, Health, General Health, Health Technology, Health Insurance, Fintech, Human Resources, Partnership, Multimedia, Software, Fraud, DRG, Nursing, Price optimization, Validation, Physician, Risk, CMS, Integrity, Health insurance

Zelis , a leading provider of healthcare technology solutions, today announced that its Payment Integrity solutions received the top honor for Payment Accuracy & Integrity Solutions (Payer) segment in the 2024 Best in KLAS Awards – Software and Services .

Key Points: 
  • Zelis , a leading provider of healthcare technology solutions, today announced that its Payment Integrity solutions received the top honor for Payment Accuracy & Integrity Solutions (Payer) segment in the 2024 Best in KLAS Awards – Software and Services .
  • The annual ranking recognizes software and services companies that excel in helping healthcare professionals improve patient care.
  • View the full release here: https://www.businesswire.com/news/home/20240207862334/en/
    This recognition follows KLAS’s inaugural report for payers, Payment Accuracy & Integrity Solutions 2023 , which identified Zelis Payment Integrity as a top overall performer based on client ratings.
  • Zelis received an overall performance score of 93.9 out of 100, outpacing the seven other companies surveyed in the payment integrity space.

TACO BELL CELEBRATES GRAND OPENING IN VISTA, CA

Retrieved on: 
Tuesday, February 6, 2024
Taco Bell, DRG, Postmates, App Store (iOS/iPadOS), Grubhub, DoorDash

VISTA, Calif., Feb. 6, 2024 /PRNewswire/ -- Diversified Restaurant Group, one of the largest Taco Bell franchisees, is celebrating the grand opening of its newest location in Southern California. The Vista Taco Bell is located at 910 E. Vista Way and welcomes the local community to join its festivities on Wednesday, February 7, from 4:30 pm to 6:00 pm.

Key Points: 
  • VISTA, Calif., Feb. 6, 2024 /PRNewswire/ -- Diversified Restaurant Group , one of the largest Taco Bell franchisees, is celebrating the grand opening of its newest location in Southern California.
  • The Vista Taco Bell is located at 910 E. Vista Way and welcomes the local community to join its festivities on Wednesday, February 7, from 4:30 pm to 6:00 pm.
  • The ceremony will be followed by a spread of Taco Bell favorites for the guests.
  • To elevate your Taco Bell experience at the new Vista location, download the Taco Bell app from the App Store or Google Play at https://www.tacobell.com/mobile , or guests can use their favorite third-party delivery service provider, including DoorDash, Grub Hub, Uber Eats, or Postmates.

New physician paper: Resolving payor-provider tension in payment integrity

Retrieved on: 
Monday, February 5, 2024
DRG, Element, Environment, Insurance, CMO, Health

NEW YORK, Feb. 5, 2024 /PRNewswire-PRWeb/ -- MedReview, Inc., a leading provider of payment integrity, utilization management and quality surveillance services, today released the whitepaper "Provider Abrasion is Healthy" by Chief Medical Officer Dr. Michael Menen. The whitepaper examines the strain that competing business goals place on relationships between payors and providers and explores how certain elements perceived as abrasive by healthcare providers may, in fact, be essential.

Key Points: 
  • NEW YORK, Feb. 5, 2024 /PRNewswire-PRWeb/ -- MedReview, Inc., a leading provider of payment integrity, utilization management and quality surveillance services, today released the whitepaper "Provider Abrasion is Healthy" by Chief Medical Officer Dr. Michael Menen.
  • These competing priorities can lead to tension between the two parties and, in some cases, a lack of cooperation.
  • What payors consider necessary steps for payment integrity, providers see as a drain on resources and a cause of diminished or delayed revenue.
  • "Payors can work with payment integrity vendors like MedReview to ease potentially volatile interactions with providers by using transparent, expedient solutions to lessen abrasion without undermining their payment integrity processes," Dr. Menen says.

TACO BELL OPENS NEW EASTVALE LOCATION

Retrieved on: 
Friday, January 5, 2024
Limonite, DoorDash, Commerce, App Store (iOS/iPadOS), Taco Bell, Grubhub, Love, Ontario Ranch, California, Lunch, Enclave and exclave, DRG, Fast food

EASTVALE, Calif., Jan. 5, 2024 /PRNewswire/ -- Diversified Restaurant Group, one of the largest Taco Bell franchisees, is unveiling a new location in Southern California. The Eastvale Taco Bell is located at 14083 Limonite Ave. and will host a grand opening celebration on Tuesday, January 9, 2024, from 3 pm – 5 pm. The grand opening event will feature a ribbon-cutting ceremony by the Eastvale Chamber of Commerce at 3 pm, followed by a spread of Taco Bell favorites for lunch.

Key Points: 
  • First 100 customers get a free Taco Bell branded cup at grand opening celebration, Jan. 9
    EASTVALE, Calif., Jan. 5, 2024 /PRNewswire/ -- Diversified Restaurant Group , one of the largest Taco Bell franchisees, is unveiling a new location in Southern California.
  • The Eastvale Taco Bell is located at 14083 Limonite Ave. and will host a grand opening celebration on Tuesday, January 9, 2024, from 3 pm – 5 pm.
  • Additionally, the first 100 customers who make a purchase will receive an exclusive Taco Bell branded cup and a free taco coupon.
  • To streamline your Taco Bell experience at the new Eastvale location, download the Taco Bell app from the App Store or Google Play at https://www.tacobell.com/mobile , or guests can use their favorite third party delivery service provider, including DoorDash, Grub Hub, Uber Eats or Postmates.

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities

Retrieved on: 
Wednesday, December 20, 2023
CSF, Immunosuppression, Partnership, ALS, GM1, Aes, Krabbe disease, FTD, Loss, ICM, PASG, Clinical trial, Plasma, Inflammation, Methylprednisolone, AAV, Toxicity, GRN, Patient, Frontotemporal dementia, Safety, Cell biology, Hepatotoxicity, MLD, DRG, Pharmaceutical industry

Additionally, the company shared updated strategic priorities aimed at further optimizing its portfolio for the treatment of neurodegenerative conditions.

Key Points: 
  • Additionally, the company shared updated strategic priorities aimed at further optimizing its portfolio for the treatment of neurodegenerative conditions.
  • "We are proud to announce initial clinical data from our upliFT-D clinical trial, which showcases the ability of PBFT02 to elevate CSF progranulin to supraphysiologic levels at the lowest tested dose, Dose 1, up to six months post-treatment.
  • The upliFT-D clinical trial evaluates PBFT02 as a single dose delivered via intra-cisterna magna (ICM) injection.
  • These strategic priorities and clinical milestones underscore Passage Bio's dedication to advancing cutting-edge, one-time genetic medicines and protecting patients and families against loss in neurodegenerative conditions.

TREND Health Partners Acquires Advent Health Partners

Retrieved on: 
Friday, December 15, 2023
Software, Professional Services, Payments, Technology, Hospitals, Artificial Intelligence, Health Technology, Health Insurance, Data Analytics, Practice Management, Finance, Health, Acquisition, William Blair & Company, LLP, DRG, Intelligence, Roger Hawkins (drummer), Barnes & Thornburg, Hospital, Holland & Knight, Management, Advent

TREND Health Partners (“TREND”), a rapidly growing provider of healthcare credit balance management and payment accuracy solutions, announced today that it has acquired Advent Health Partners, Inc. (“Advent”).

Key Points: 
  • TREND Health Partners (“TREND”), a rapidly growing provider of healthcare credit balance management and payment accuracy solutions, announced today that it has acquired Advent Health Partners, Inc. (“Advent”).
  • “Rarely do you come across two companies with such complementary capabilities and aligned visions as what we found with TREND and Advent.
  • We are very excited to welcome the Advent team into our organization,” said Sarah Armstrong, CEO of TREND.
  • OM Partners, LLC served as exclusive financial advisor and Barnes & Thornburg LLP served as legal counsel to Advent.

TACO BELL OPENS RENOVATED SHAWNEE MISSION LOCATION

Retrieved on: 
Thursday, December 14, 2023
DRG, Food, Love, Google Play, DoorDash, App store, Taco Bell, App Store (iOS/iPadOS), Fast food

SHAWNEE MISSION, Kan., Dec. 14, 2023 /PRNewswire/ -- Diversified Restaurant Group (DRG), one of the largest Taco Bell franchisees, will host a ribbon-cutting ceremony for the newly renovated Taco Bell at 12014 Shawnee Mission Pkwy, Kansas.

Key Points: 
  • SHAWNEE MISSION, Kan., Dec. 14, 2023 /PRNewswire/ -- Diversified Restaurant Group (DRG), one of the largest Taco Bell franchisees, will host a ribbon-cutting ceremony for the newly renovated Taco Bell at 12014 Shawnee Mission Pkwy, Kansas.
  • Guests who visit the restaurant will find an updated dining experience with new communal seating and renovated restrooms.
  • "We are thrilled to unveil the reimagined Taco Bell experience at our newly renovated location!
  • To place an order with the Overland Park Taco Bell, download the Taco Bell app or use your favorite delivery provider from the App Store or Google Play.